Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share
-
Shares outstanding
-
133,765,508
-
Total 13F shares
-
7,519,944
-
Share change
-
-4,273
-
Total reported value
-
$48,501,000
-
Put/Call ratio
-
69%
-
Price per share
-
$6.45
-
Number of holders
-
36
-
Value change
-
-$227,089
-
Number of buys
-
12
-
Number of sells
-
22
Institutional Holders of Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) as of Q4 2018
As of 31 Dec 2018,
Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,519,944 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, Vanguard Group Inc, Rock Springs Capital Management LP, Man Group plc, NORGES BANK, UBS Group AG, Quinn Opportunity Partners LLC, PEAK6 Investments LLC, CITADEL ADVISORS LLC, and BANK OF AMERICA CORP /DE/.
This page lists
36
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.